Metraipolis › archive › dc_f613f47ef355

TRIM33 Reverses Cisplatin Resistance in Non-Small Cell Lung Cancer by Regulating the PI3K/AKT Pathway via Ubiquitination-Mediated Degradation of LPCAT1 — Europe PMC PMID:42147264

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42147264
DOI
10.14740/wjon2729
License (as archived)
solo-consultazione
Archived
2026-11-02T13:36:02.312Z
SHA-256 of the archived text
cc0ab121a22a2ce164236b8843d5d5966f28803049f20d9a19463fe689e15f95
Stable URL of this page
https://metraipolis.com/documento/dc_f613f47ef355

How to cite

TRIM33 Reverses Cisplatin Resistance in Non-Small Cell Lung Cancer by Regulating the PI3K/AKT Pathway via Ubiquitination-Mediated Degradation of LPCAT1 — Europe PMC PMID:42147264 — Europe PMC (en), https://europepmc.org/article/MED/42147264 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f613f47ef355 (Metraipolis archive dc_f613f47ef355, sha256 cc0ab121a22a2ce164236b8843d5d5966f28803049f20d9a19463fe689e15f95)
BibTeX
@misc{dcf613f47ef355,
  title = {TRIM33 Reverses Cisplatin Resistance in Non-Small Cell Lung Cancer by Regulating the PI3K/AKT Pathway via Ubiquitination-Mediated Degradation of LPCAT1 — Europe PMC PMID:42147264},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42147264},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f613f47ef355; sha256 cc0ab121a22a2ce164236b8843d5d5966f28803049f20d9a19463fe689e15f95},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42147264. Agents can read the archived copy with the MCP tool read_document.